ATE535618T1 - Spezifisches verfahren zum nachweis von prostatakrebs auf grundlage des pca3-gens sowie kits dafür - Google Patents

Spezifisches verfahren zum nachweis von prostatakrebs auf grundlage des pca3-gens sowie kits dafür

Info

Publication number
ATE535618T1
ATE535618T1 AT04763058T AT04763058T ATE535618T1 AT E535618 T1 ATE535618 T1 AT E535618T1 AT 04763058 T AT04763058 T AT 04763058T AT 04763058 T AT04763058 T AT 04763058T AT E535618 T1 ATE535618 T1 AT E535618T1
Authority
AT
Austria
Prior art keywords
pca3
kits
rna
methods
prostate
Prior art date
Application number
AT04763058T
Other languages
English (en)
Inventor
Jack Schalken
Gerald Verhaegh
Daphne Hessels
Frank Smit
Original Assignee
Stichting Katholieke Univ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stichting Katholieke Univ filed Critical Stichting Katholieke Univ
Application granted granted Critical
Publication of ATE535618T1 publication Critical patent/ATE535618T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT04763058T 2003-06-30 2004-06-30 Spezifisches verfahren zum nachweis von prostatakrebs auf grundlage des pca3-gens sowie kits dafür ATE535618T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CA002432365A CA2432365A1 (en) 2003-06-30 2003-06-30 Specific method of prostate cancer detection based on pca3, and kits therefore
PCT/EP2004/007124 WO2005003387A2 (en) 2003-06-30 2004-06-30 Specific method of prostate cancer detection based on pca3 gene, and kits therefor

Publications (1)

Publication Number Publication Date
ATE535618T1 true ATE535618T1 (de) 2011-12-15

Family

ID=33557630

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04763058T ATE535618T1 (de) 2003-06-30 2004-06-30 Spezifisches verfahren zum nachweis von prostatakrebs auf grundlage des pca3-gens sowie kits dafür

Country Status (8)

Country Link
US (3) US20050164223A1 (de)
EP (1) EP1639138B1 (de)
JP (2) JP4741481B2 (de)
AT (1) ATE535618T1 (de)
AU (2) AU2004254043A1 (de)
CA (1) CA2432365A1 (de)
ES (1) ES2377485T3 (de)
WO (1) WO2005003387A2 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69840669D1 (de) * 1997-04-10 2009-04-30 Stichting Katholieke Univ Pca3, pca3-gene und verfahren zu ihrer verwendung
US20060204989A1 (en) * 1998-09-22 2006-09-14 Kopreski Michael S Comparative analysis of extracellular RNA species
EP1222266B1 (de) * 1999-09-29 2006-03-29 Diagnocure Inc. Pca3 mrna in gutartigen und bösartigen prostatageweben
US20100159464A1 (en) * 2001-11-05 2010-06-24 Oncomedx, Inc. Method for Detection of DNA Methyltransferase RNA in Plasma and Serum
EP1592809B1 (de) 2003-02-07 2013-04-10 Diagnocure Inc. Verfahren zum nachweis von prostatakrebs in einer probe
CA2432365A1 (en) * 2003-06-30 2004-12-30 Jack A. Schalken Specific method of prostate cancer detection based on pca3, and kits therefore
US11105808B2 (en) 2004-11-12 2021-08-31 Health Discovery Corporation Methods for screening, predicting and monitoring prostate cancer
CA2491067A1 (en) 2004-12-24 2006-06-24 Stichting Katholieke Universiteit Mrna rations in urinary sediments and/or urine as a prognostic marker for prostate cancer
CA2814598A1 (en) 2005-09-12 2007-03-22 The Regents Of The University Of Michigan Recurrent gene fusions in prostate cancer
US9957569B2 (en) 2005-09-12 2018-05-01 The Regents Of The University Of Michigan Recurrent gene fusions in prostate cancer
US9051601B2 (en) * 2006-08-01 2015-06-09 Gen-Probe Incorporated Methods of nonspecific target capture of nucleic acids
CA2692793C (en) 2007-07-06 2014-05-20 The Regents Of The University Of Michigan Mipol1-etv1 gene rearrangements
WO2009140741A1 (en) * 2008-05-23 2009-11-26 The University Of Queensland Agents and methods for diagnosing the presence or risk of prostate cancer
JP2010233542A (ja) * 2009-03-31 2010-10-21 Kanazawa Univ Ｒａｇｅ遺伝子の２種類のスプライシングバリアントを区別して増幅可能なプライマーセット及びプローブ
EP2478120B1 (de) 2009-09-17 2015-09-02 The Regents Of The University Of Michigan Rezidivierende genfusionen bei prostatakrebs
US9315802B2 (en) 2009-12-30 2016-04-19 Quest Diagnostics Investments Incorporated RNA isolation from soluble urine fractions
EP2407554A1 (de) 2010-07-14 2012-01-18 Fundacio Institut de Recerca de l'Hospital Universitari Vall d'Hebron Verfahren und Kits zur Diagnose von Prostatakrebs
EP2407555A1 (de) 2010-07-14 2012-01-18 Fundació Institut de Recerca Hospital Universitari Vall d'Hebron, Fundació Privada Verfahren und Kits zur Diagnose von Prostatakrebs
US8945556B2 (en) 2010-11-19 2015-02-03 The Regents Of The University Of Michigan RAF gene fusions
WO2012092490A1 (en) 2010-12-30 2012-07-05 Quest Diagnostics Investments Incorporated Diagnosis of prostate cancer
WO2014003580A1 (en) * 2012-06-28 2014-01-03 Caldera Health Ltd Targeted rna-seq methods and materials for the diagnosis of prostate cancer
CN104357451B (zh) * 2014-12-02 2016-09-21 广州市番禺区中心医院 针对dd3基因的小干扰rna及其表达载体构建与应用
EP3448998B1 (de) 2016-04-27 2020-06-03 Gen-Probe Incorporated Reagens für blutzelllyse
WO2018204408A1 (en) * 2017-05-02 2018-11-08 Sanford Burnham Prebys Medical Discovery Institute Methods of diagnosing and treating alzheimer's disease
CN117265112B (zh) * 2023-09-28 2024-05-31 上海仁度生物科技股份有限公司 一种前列腺癌的数字微液滴rna扩增检测系统及pca3基因在该系统中的应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0558697A1 (de) * 1991-06-28 1993-09-08 Massachusetts Institute Of Technology Lokale oligonukleotiden Behandlung
CA2148350A1 (en) * 1992-10-29 1994-05-11 Carlo Croce Methods of detecting micrometastasis of prostate cancer
US5674682A (en) * 1992-10-29 1997-10-07 Thomas Jefferson University Nucleic acid primers for detecting micrometastasis of prostate cancer
DE69840669D1 (de) 1997-04-10 2009-04-30 Stichting Katholieke Univ Pca3, pca3-gene und verfahren zu ihrer verwendung
EP0975807B1 (de) * 1997-05-02 2006-09-27 Gen-Probe Incorporated Zwei-schritt hybridisierung und einfang von einem polynukleotid
EP1222266B1 (de) * 1999-09-29 2006-03-29 Diagnocure Inc. Pca3 mrna in gutartigen und bösartigen prostatageweben
EP1592809B1 (de) * 2003-02-07 2013-04-10 Diagnocure Inc. Verfahren zum nachweis von prostatakrebs in einer probe
CA2432365A1 (en) * 2003-06-30 2004-12-30 Jack A. Schalken Specific method of prostate cancer detection based on pca3, and kits therefore

Also Published As

Publication number Publication date
CA2432365A1 (en) 2004-12-30
JP4741481B2 (ja) 2011-08-03
WO2005003387A3 (en) 2005-03-31
WO2005003387A2 (en) 2005-01-13
US20050164223A1 (en) 2005-07-28
US20090233285A1 (en) 2009-09-17
AU2010201771B2 (en) 2013-01-10
JP2009513103A (ja) 2009-04-02
US20120309006A1 (en) 2012-12-06
AU2010201771A1 (en) 2010-06-03
EP1639138B1 (de) 2011-11-30
JP2011172574A (ja) 2011-09-08
AU2004254043A1 (en) 2005-01-13
EP1639138A2 (de) 2006-03-29
ES2377485T3 (es) 2012-03-28

Similar Documents

Publication Publication Date Title
ATE535618T1 (de) Spezifisches verfahren zum nachweis von prostatakrebs auf grundlage des pca3-gens sowie kits dafür
Zastrow‐Hayes et al. Southern‐by‐sequencing: a robust screening approach for molecular characterization of genetically modified crops
ES2648564T3 (es) Método ultrasensible para la detección in situ de ácidos nucleicos
CN101892317B (zh) Hla高分辨基因测序试剂盒
DK1725573T3 (da) Fremgangsmåde og materialer ved anvendelse af signalsonder
FR2863274B1 (fr) Procede d'evaluation quantitative d'un rearrangement ou d'une recombinaison genetique ciblee d'un individu et ses applications.
DE60128908D1 (de) Verfahren zum Nachweis und zur Lokalisierung von Genen in situ durch Hybridisierung einer verzweigten DNA
WO2005068664A3 (en) Cell-type-specific patterns of gene expression
US10011867B2 (en) Targeted sequencing technique for whole genome DNA methylation
CN102586420B (zh) 一种检测乳腺癌易感基因的方法及试剂盒
DE60333295D1 (de) Verfahren zum nachweis abnormal methylierter nukleinsäure in heterogenen biologischen proben
WO2005083115A3 (de) Verfahren zur erkennung von sepsis
WO2000044940A3 (en) Nucleic acid sequences for detecting genetic markers for cancer in a biological sample
CN110452959B (zh) 一种黄草乌实时定量pcr内参基因的筛选方法
DE502008002136D1 (de) Kontrollgene zur normalisierung von genexpressionsanalysedaten
ATE546550T1 (de) Verfahren zum nachweis von hpv sowie sonden, primer und kits
CN107090494A (zh) 与谷子码粒数性状相关的分子标记及其检测引物和应用
ATE451617T1 (de) Verfahren zur erkennung eines kolonkrebsmarkers
CN109517819A (zh) 一种用于检测多靶点基因突变、甲基化修饰和/或羟甲基化修饰的检测探针、方法和试剂盒
JP2007006711A5 (de)
CN101914625B (zh) 焦磷酸测序法检测牙釉质蛋白基因进行性别鉴定的试剂盒及方法
WO2002004683A3 (en) Method of detecting an increased susceptibility to breast cancer
KR101683086B1 (ko) 유전자의 발현량 및 메틸화 프로필을 활용한 돼지의 산자수 예측방법
CN104152570B (zh) 一种基底细胞癌易感基因snp多态性检测试剂盒
ATE440138T1 (de) Mutationen des parkin-gens, zusammensetzungen, verfahren und verwendungen